NCT01600170View on ClinicalTrials.gov

Downmodulating Monocyte Activation for HIV-1 Associated Neurocognitive Disorders (HAND)

PHASE4CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

October 31, 2017

Study Completion Date

October 31, 2017

Conditions
HIV Dementia
Interventions
DRUG

Atorvastatin (generic Lipitor)

Atorvastatin is an FDA approved prescription drug which is frequently used to lower cholesterol levels.It is available in the form of tablets ranging in dose from 10-80mg.

DRUG

placebo

A substance containing no medication and prescribed or given to reinforce a patient's expectation to get well.

Trial Locations (1)

19104

University of Pennsylvania School of Medicine, Philadelphia

All Listed Sponsors
lead

University of Pennsylvania

OTHER

NCT01600170 - Downmodulating Monocyte Activation for HIV-1 Associated Neurocognitive Disorders (HAND) | Biotech Hunter | Biotech Hunter